<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39319057</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2234-943X</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in oncology</Title><ISOAbbreviation>Front Oncol</ISOAbbreviation></Journal><ArticleTitle>Mendelian randomization provides causal association between COVID-19 and thyroid cancer: insights from a multi-cancer analysis.</ArticleTitle><Pagination><StartPage>1419020</StartPage><MedlinePgn>1419020</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1419020</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fonc.2024.1419020</ELocationID><Abstract><AbstractText>Since the onset of the COVID-19 pandemic, the SARS-CoV-2 virus has caused over 600 million confirmed infections and more than 6.8 million deaths worldwide, with ongoing implications for human health. COVID-19 has been extensively documented to have extrapulmonary manifestations due to the widespread expression of necessary ACE2 receptors in the human body. Nevertheless, the association between COVID-19 and cancer risk remains inadequately explored. This study employs Mendelian randomization (MR) methods to examine the causal relationship between genetic variations associated with COVID-19 and the risk of developing cancer. The findings indicate that COVID-19 has negligible impact on most cancer risks. Interestingly, a higher COVID-19 impact is associated with a decreased risk of thyroid cancer. In summary, our findings demonstrate a genetic correlation between COVID-19 and thyroid cancer, contributing to our understanding of the interplay between COVID-19 and cancer risk.</AbstractText><CopyrightInformation>Copyright © 2024 Li, Du, Ma, Cai, Liu and He.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shuhong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Oncology, Chengdu Second People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Zedong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Oncology, Chengdu Second People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Oncology, Chengdu Second People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Oncology, Chengdu Second People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Oncology, Chengdu Second People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Oncol</MedlineTA><NlmUniqueID>101568867</NlmUniqueID><ISSNLinking>2234-943X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cancer risk</Keyword><Keyword MajorTopicYN="N">thyroid</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319057</ArticleId><ArticleId IdType="pmc">PMC11419959</ArticleId><ArticleId IdType="doi">10.3389/fonc.2024.1419020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Coronavirus disease (COVID-19) situation reports (2023). Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. (Accessed October 07, 2023)</Citation></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. (2020) 20:533–4. doi: 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>
CSSEGISandData . COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (2023). Available online at: https://github.com/CSSEGISandData/COVID-19 (Accessed October 6, 2023).</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. (2020) 323:1239–42. doi: 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf UM, Abokor AA, Edwards JM, Waigi EW, Royfman RS, Hasan SA-M, et al. . SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiol Genomics. (2021) 53:7. doi: 10.1152/physiolgenomics.00087.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00087.2020</ArticleId><ArticleId IdType="pmc">PMC7900915</ArticleId><ArticleId IdType="pubmed">33275540</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. . Extrapulmonary manifestations of COVID-19. Nat Med. (2020) 26.:1–11. doi: 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol-cell Ph. (2022) 322:C1–C11. doi: 10.1152/ajpcell.00375.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds P, Williams S, Harvala H. Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit? J Gen Virol. (2020) 102:1545. doi: 10.1099/jgv.0.001545</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001545</ArticleId><ArticleId IdType="pmc">PMC8222868</ArticleId><ArticleId IdType="pubmed">33331810</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivaldi G, Pfeffer PE, Talaei M, Basera TJ, Shaheen SO, Martineau AR. Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study. eClinicalMedicine. (2023) 65. doi: 10.1016/j.eclinm.2023.102251</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102251</ArticleId><ArticleId IdType="pmc">PMC10721552</ArticleId><ArticleId IdType="pubmed">38106559</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskett WI, Qureshi AI, Shyu D, Armer JM, Shyu CR. COVID-specific long-term sequelae in comparison to common viral respiratory infections: an analysis of 17 487 infected adult patients. Open Forum Infect Dis. (2022) 10:ofsac683. doi: 10.1093/ofid/ofac683</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac683</ArticleId><ArticleId IdType="pmc">PMC9846186</ArticleId><ArticleId IdType="pubmed">36686632</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601–15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Khiali S, Rezagholizadeh A, Entezari-Maleki T. SARS-CoV-2 and probable lung cancer risk. Bioimpacts. (2022) 12:291–2. doi: 10.34172/bi.2022.23266</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/bi.2022.23266</ArticleId><ArticleId IdType="pmc">PMC9124879</ArticleId><ArticleId IdType="pubmed">35677665</ArticleId></ArticleIdList></Reference><Reference><Citation>Jyotsana N, King MR. The impact of COVID-19 on cancer risk and treatment. Cell Mol Bioeng. (2020) 13:285–91. doi: 10.1007/s12195-020-00630-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12195-020-00630-3</ArticleId><ArticleId IdType="pmc">PMC7323371</ArticleId><ArticleId IdType="pubmed">32837583</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell PJ. Epstein-barr virus and cancer. Annu Rev Pathol. (2019) 14:29–53. doi: 10.1146/annurev-pathmechdis-012418-013023</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-013023</ArticleId><ArticleId IdType="pubmed">30125149</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. (2020) 33:e00046–19. doi: 10.1128/CMR.00046-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00046-19</ArticleId><ArticleId IdType="pmc">PMC7048015</ArticleId><ArticleId IdType="pubmed">32102898</ArticleId></ArticleIdList></Reference><Reference><Citation>Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. (2003) 16:1–17. doi: 10.1128/CMR.16.1.1-17.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.16.1.1-17.2003</ArticleId><ArticleId IdType="pmc">PMC145302</ArticleId><ArticleId IdType="pubmed">12525422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. (2008) 27:1133–63. doi: 10.1002/sim.3034</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3034</ArticleId><ArticleId IdType="pubmed">17886233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Tilling K, Smith GD. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PloS Genet. (2017) 13:e1007081. doi: 10.1371/journal.pgen.1007081</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007081</ArticleId><ArticleId IdType="pmc">PMC5711033</ArticleId><ArticleId IdType="pubmed">29149188</ArticleId></ArticleIdList></Reference><Reference><Citation>
IEU OpenGWAS project. Available online at: https://gwas.mrcieu.ac.uk/ (Accessed September 27, 2023).</Citation></Reference><Reference><Citation>Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. (2013) 178:1177–84. doi: 10.1093/aje/kwt084</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt084</ArticleId><ArticleId IdType="pmc">PMC3783091</ArticleId><ArticleId IdType="pubmed">23863760</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. (2016) 40:304–14. doi: 10.1002/gepi.21965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology. (2017) 28:30–42. doi: 10.1097/EDE.0000000000000559</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000559</ArticleId><ArticleId IdType="pmc">PMC5133381</ArticleId><ArticleId IdType="pubmed">27749700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Spiller W, Del Greco MF, Sheehan N, Thompson J, Minelli C, et al. . Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol. (2018) 47:1264–78. doi: 10.1093/ije/dyy101</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy101</ArticleId><ArticleId IdType="pmc">PMC6124632</ArticleId><ArticleId IdType="pubmed">29961852</ArticleId></ArticleIdList></Reference><Reference><Citation>
R Core Team . R: A language and environment for statistical computing. (2022). Available at: https://www.r-project.org/.</Citation></Reference><Reference><Citation>
Dayimu A. forestploter: create flexible forest plot (2023). Available online at: https://github.com/adayim/forestploter. (Accessed October 07, 2023)</Citation></Reference><Reference><Citation>Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. (2021) 9:e002266. doi: 10.1136/jitc-2020-002266</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-002266</ArticleId><ArticleId IdType="pmc">PMC7978268</ArticleId><ArticleId IdType="pubmed">33737345</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Bai H, Qiao H, Du C, Yao P, Zhang Y, et al. . Causal effects of COVID-19 on cancer risk: A Mendelian randomization study. J Med Virol. (2023) 95:e28722. doi: 10.1002/jmv.28722</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28722</ArticleId><ArticleId IdType="pubmed">37185860</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. . A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. (2020) 49:411–7. doi: 10.3760/cma.j.cn112151-20200312-00193</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112151-20200312-00193</ArticleId><ArticleId IdType="pubmed">32172546</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron P. Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management. Ann Endocrinol (Paris). (2020) 81:507–10. doi: 10.1016/j.ando.2020.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ando.2020.09.001</ArticleId><ArticleId IdType="pmc">PMC7498405</ArticleId><ArticleId IdType="pubmed">32950466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-coV-2’s reliance on ACE2. Endocrinology. (2020) 161:bqaa108. doi: 10.1210/endocr/bqaa108</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa108</ArticleId><ArticleId IdType="pmc">PMC7454499</ArticleId><ArticleId IdType="pubmed">32652001</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissue. Infect Dis Poverty. (2020) 9:45. doi: 10.1186/s40249-020-00662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intens Care Med. (2020) 46:846–8. doi: 10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and ultrastructural findings of fatal infections in Washington State: case series COVID-19, et al. . Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet. (2020) 396:320–32. doi: 10.1016/S0140-6736(20)31305-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31305-2</ArticleId><ArticleId IdType="pmc">PMC7365650</ArticleId><ArticleId IdType="pubmed">32682491</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, oklahoma, USA. Am J Clin Pathol. (2020) 153:725–33. doi: 10.1093/ajcp/aqaa062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa062</ArticleId><ArticleId IdType="pmc">PMC7184436</ArticleId><ArticleId IdType="pubmed">32275742</ArticleId></ArticleIdList></Reference><Reference><Citation>Boechat JL, Chora I, Morais A, Delgado L. The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives. Pulmonology. (2021) 27:423–37. doi: 10.1016/j.pulmoe.2021.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2021.03.008</ArticleId><ArticleId IdType="pmc">PMC8040543</ArticleId><ArticleId IdType="pubmed">33867315</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrollahi H, Talepoor AG, Saleh Z, Eshkevar Vakili M, Heydarinezhad P, et al. . Immune responses in mildly versus critically ill COVID-19 patients. Front Immunol. (2023) 14:1077236. doi: 10.3389/fimmu.2023.1077236</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1077236</ArticleId><ArticleId IdType="pmc">PMC9923185</ArticleId><ArticleId IdType="pubmed">36793739</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. (2023) 401:1531–44. doi: 10.1016/S0140-6736(23)00020-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00020-X</ArticleId><ArticleId IdType="pubmed">37023783</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>